New Research Findings Could Help Prevent Cases of Triple-negative Breast Cancer
Lajos Pusztai, M.D., D.Phil. from Criterium’s Academic Breast Cancer Consortium (ABRCC) and the Yale Cancer Center highlights research findings that could potentially help decrease the incidence of triple-negative breast cancer.
Learn more about the findings from this retrospective analysis
Test your knowledge of HER2-Positive Breast Cancer
Test your knowledge of HER2-Positive Breast Cancer with a quiz co-written by Pavani Chalasani, MD, MPH from Criterium’s Academic Breast Cancer Consortium (ABRCC).
Take the quiz to test your knowledge
Principal Investigator to Lead National Thoracic Oncology Program
Christine Lovly, M.D., Ph.D. from Criterium’s Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC) will spearhead City of Hope’s new national thoracic oncology program.
Learn more about the new thoracic oncology program
Sequencing Strategies in Advanced Hormone Receptor–positive Breast Cancer
Ruth O’Regan, M.D. from Criterium’s Academic Breast Cancer Consortium (ABRCC) and the James P. Wilmot Cancer Institute discusses sequencing strategies in advanced hormone receptor–positive breast cancer.
Watch Dr. O’Regan discuss sequencing strategies
Rhenium Obisbemeda Improves Survival in Recurrent Glioblastoma
Andrew Brenner, M.D., Ph.D., from Criterium’s Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC) and University of Texas Health Science Center discussed results from the ReSPECT-GBM trial for patients with glioblastoma.